Project Grant R01AR087375
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $581,451 under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award, effective June 1, 2026, through March 31, 2031, supports basic research investigating the neuroimmune mechanisms underlying pruritus (itch). The research project examines how commensal microbiota-induced immune...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Icahn School of Medicine at Mount Sinai a $250,396 Project Grant (R21 mechanism) effective September 5, 2025, through August 31, 2027, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award funds research to unravel epigenetic and transcriptional control mechanisms in skin cells from populations with historically understudied...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $528,558 (awarded September 1, 2025, with completion by August 31, 2030) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research project investigates T-cell plasticity mechanisms underlying treatment resistance and paradoxical inflammatory side effects in atopic...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai received a $100,228 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective November 16, 2026, with a completion date of May 31, 2029. The award funds basic science research investigating mechanosensation in muscle-resident mesenchymal stromal cells, specifically...
- Federal Grant Award Summary New York University School of Medicine received a $1.92 million Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025, through August 31, 2028. This research project investigates the plasticity of melanocyte stem cells (MCSCs) and mature melanocytes (MCs) within adult hair follicles, specifically examining...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Columbia University's Health Sciences Division a Project Grant of $384,519 on August 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award funds research investigating the mechanistic role of dietary gluten and gut microbiota in alopecia areata (AA), a chronic autoimmune disease of the hair follicle. The research will...
- Federal Project Grant Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $4.13 million Project Grant to Icahn School of Medicine at Mount Sinai effective September 1, 2025, through August 31, 2028, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The project, titled "Uncovering Novel Microbial Factors That Enhance Wound Repair," delivers biomedical research services focused on identifying and...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $134,261 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025, through March 31, 2028. The award funds genetic and genomic analysis research examining the role of Electron Transport Chain (ETC) Complex II in mammalian skin development....
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a Project Grant of $224,100 (effective September 15, 2025, through August 31, 2028) to the Regents of the University of California at Riverside to support research on epigenetic factors controlling epidermal stem cell longevity in adult skin. The project addresses fundamental mechanisms underlying age-related skin degradation, including epidermal atrophy, hair loss, and...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Icahn School of Medicine at Mount Sinai a $2.06 million Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) beginning June 1, 2026 and concluding May 31, 2030. The award supports the development and clinical validation of an engineered messenger ribonucleic acid (mRNA) therapeutic designed to promote rotator cuff muscle regeneration...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $551,321 under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) for the period July 1, 2026 through May 31, 2031. This grant supports fundamental research investigating the cellular and molecular mechanisms of dermal condensate (DC) formation during embryonic hair follicle development. The research focuses on understanding how fibroblast precursor cells migrate and aggregate to form dermal papilla clusters—specialized signaling centers critical for hair follicle morphogenesis and regeneration. The primary deliverables include mechanistic insights into axon guidance signaling pathways that regulate pre-dermal condensate cell migration and clustering, supported by comprehensive molecular and functional analyses utilizing transcriptomics, immunofluorescence, in situ hybridization, and in vivo ablation assays. Research outputs will advance understanding of how to preserve the hair-inductive capacity of dermal papilla cells, with implications for developing cell-based regenerative therapies for hair loss. The project represents targeted investment in basic dermatological science within NIAMS's broader portfolio supporting research into causes, treatment, and prevention of skin diseases and conditions.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $551.3k | 5/26/26 |